A day before current Shire PLC employees globally get their new takeda.com email addresses, the acquisition’s most public champion Christophe Weber said he is “excited and confident” about the combined company’s future and Takeda Pharmaceutical Co. Ltd.’s transformation into what he sees as “a global, values-based, R&D-driven biopharmaceutical leader.”
The Japanese firm’s president and CEO told a Tokyo press conference on Jan
After months of pre-closing preparations, working through the procedures and logistics, and facing some hostility from influential shareholders in Japan, the CEO seemed to have retained a clear focus on the single most important priority